Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
Jiangsu Bioperfectus Technologies Co Ltd
Net Income (Common)
Jiangsu Bioperfectus Technologies Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
|
Net Income (Common)
¥1.8B
|
CAGR 3-Years
179%
|
CAGR 5-Years
112%
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Net Income (Common)
¥2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Net Income (Common)
¥737.7m
|
CAGR 3-Years
12%
|
CAGR 5-Years
18%
|
CAGR 10-Years
19%
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Net Income (Common)
¥1.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Net Income (Common)
¥1.7B
|
CAGR 3-Years
45%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Net Income (Common)
¥1.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
See Also
What is Jiangsu Bioperfectus Technologies Co Ltd's Net Income (Common)?
Net Income (Common)
1.8B
CNY
Based on the financial report for Dec 31, 2022, Jiangsu Bioperfectus Technologies Co Ltd's Net Income (Common) amounts to 1.8B CNY.
What is Jiangsu Bioperfectus Technologies Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
112%
Over the last year, the Net Income (Common) growth was 53%. The average annual Net Income (Common) growth rates for Jiangsu Bioperfectus Technologies Co Ltd have been 179% over the past three years , 112% over the past five years .